ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

Core Viewpoint - Rocket Doctor AI Inc. is initiating a non-brokered private placement to raise a minimum of approximately $3,000,000 through the sale of 4,285,715 units at a price of $0.70 per unit [1][6] Group 1: Offering Details - Each unit consists of one common share and one warrant, with the warrant allowing the purchase of one common share at an exercise price of $0.85 for 12 months post-closing [2] - The offering is conducted under the LIFE Exemption, allowing it to be available to purchasers in all Canadian provinces except Quebec, with no hold period for the issued units [3] - The offering is expected to close on or about January 19, 2026, subject to conditions including receiving subscriptions for the minimum amount and necessary approvals [6] Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for digital marketing, customer acquisition, operating and administrative expenses, research and development, and general working capital [5] Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions aimed at improving access to quality healthcare throughout the patient journey, supported by a clinically validated decision support system [8] - The company has empowered over 300 MDs to manage more than 700,000 patient visits, enhancing efficiency and expanding patient access to care [9] - The technology aims to reduce administrative burdens and improve physician-patient interactions, particularly targeting underserved communities in Canada and supporting patients on Medicaid and Medicare in the U.S. [10][11]